1.18Open0.65Pre Close54 Volume3.05K Open Interest75.00Strike Price5.83KTurnover47.72%IV2.94%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.84Extrinsic Value100Contract SizeAmericanOptions Type-0.3402Delta0.0975Gamma87.33Leverage Ratio-0.1855Theta-0.0027Rho-29.71Eff Leverage0.0289Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet